Synaptic vesicle mimics affect the aggregation of wild-type and A53T α-synuclein variants differently albeit similar membrane affinity by Rocha, Sandra et al.
Synaptic vesicle mimics affect the aggregation of wild-type and
A53T a-synuclein variants differently albeit similar membrane
affinity
Downloaded from: https://research.chalmers.se, 2021-08-31 13:02 UTC
Citation for the original published paper (version of record):
Rocha, S., Kumar, R., Horvath, I. et al (2019)
Synaptic vesicle mimics affect the aggregation of wild-type and A53T a-synuclein variants
differently albeit similar membrane affinity
Protein engineering, design &amp; selection : PEDS, 32(2): 59-66
http://dx.doi.org/10.1093/protein/gzz021
N.B. When citing this work, cite the original published paper.
research.chalmers.se offers the possibility of retrieving research publications produced at Chalmers University of Technology.
It covers all kind of research output: articles, dissertations, conference papers, reports etc. since 2004.
research.chalmers.se is administrated and maintained by Chalmers Library
(article starts on next page)
59
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License
(http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is
properly cited. For commercial re-use, please contact journals.permissions@oup.com
Protein Engineering, Design and Selection, 2019, vol. 32 no. 2, pp. 59–66
doi: 10.1093/protein/gzz021
Advance Access Publication Date: 30 September 2019
Original Article
Original Article
Synaptic vesicle mimics affect the aggregation
of wild-type and A53T α-synuclein variants
differently albeit similar membrane affinity
Sandra Rocha*,1, Ranjeet Kumar1, Istvan Horvath1, and Pernilla
Wittung-Stafshede ,*,1
1Department of Biology and Biological Engineering, Chalmers University of Technology, 412 96 Gothenburg, Sweden
*To whom correspondence should be addressed. E-mail: pernilla.wittung@chalmers.se; sandra.rocha@chalmers.se
Edited by: Dr Valerie Daggett
Received 19 June 2019; Revised 19 June 2019; Editorial Decision 1 July 2019; Accepted 1 July 2019
Abstract
α-Synuclein misfolding results in the accumulation of amyloid fibrils in Parkinson’s disease.
Missense protein mutations (e.g. A53T) have been linked to early onset disease. Although
α-synuclein interacts with synaptic vesicles in the brain, it is not clear what role they play in
the protein aggregation process. Here, we compare the effect of small unilamellar vesicles (lipid
composition similar to synaptic vesicles) on wild-type (WT) and A53T α-synuclein aggregation.
Using biophysical techniques, we reveal that binding affinity to the vesicles is similar for the two
proteins, and both interact with the helix long axis parallel to the membrane surface. Still, the
vesicles affect the aggregation of the variants differently: effects on secondary processes such as
fragmentation dominate for WT, whereas for A53T, fibril elongation is mostly affected. We speculate
that vesicle interactions with aggregate intermediate species, in addition to monomer binding, vary
between WT and A53T, resulting in different consequences for amyloid formation.
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Introduction
The intrinsically disordered protein α-synuclein is expressed
ubiquitously in the brain (Kim et al., 2014). Proteinaceous deposits
composed of amyloid fibrils of α-synuclein have been identified as the
major constituent of Lewy bodies, intracellular neuronal inclusions
that are the hallmark of a related group of neurodegenerative
disorders including Parkinson’s disease (PD) (Spillantini et al.,
1998; Kim et al., 2014). A series of mutations in the α-synuclein
gene linked to early-onset forms of the disorder, including A53T,
have been identified in families with PD (Polymeropoulos et al.,
1997; Kruger et al., 1998). The kinetics of the aggregation process
of mutants have been extensively studied but the mechanistic
effects of the mutations on α-synuclein amyloid formation have
yet to be understood (Conway et al., 2000; Li et al., 2001, 2002;
Lemkau et al., 2012). In most reported studies, A53T variant
aggregates at faster rates compared to the wild-type (WT) protein.
Interestingly, single-molecule Förster resonance energy transfer
studies showed that WT and A53T α-synuclein variants form
similar concentrations of oligomers during the lag phase of the
aggregation but the conversion from initially formed oligomers
to more compact aggregates, rich in extended β-sheet structures,
varies considerably between the variants (Tosatto et al., 2015). A
more detailed investigation of the effect of lipid membranes on the
amyloid fibril formation by α-synuclein is physiologically relevant
considering that the protein is present in presynaptic nerve termini
and appears to interact with synaptic vesicles (Maroteaux et al.,
1988; Nakajo et al., 1990; Iwai et al., 1995). α-Synuclein membrane
binding is driven by the N-terminus of the protein and leads to
α-helix structure formation (Bartels et al., 2010). It has been estab-
lished that the effect of membranes on the aggregation of α-synuclein
is dependent on the lipid-to-protein (L/P) ratio, the chemical structure
of the lipids and the lipid molecule ordering (Pfefferkorn et al., 2012;
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Galvagnion et al., 2016; Kiskis et al., 2017). Studies have shown that
lipid membranes can both speed up and slow down the aggregation of
α-synuclein (Zhu et al., 2003; Martinez et al., 2007; Reynolds et al.,
2011; Pfefferkorn et al., 2012; Hellstrand et al., 2013; Galvagnion
et al., 2015, 2016; Kiskis et al., 2017). Furthermore, single point
mutations in the sequence of α-synuclein can affect the protein–
membrane interaction. The aggregation of the A53T mutant, for
example, was found to be enhanced in the presence of DMPS
(1,2-dimyristoyl-sn-glycero-3-phospho-l-serine) vesicles when com-
pared to the WT, again suggesting differences between the two
variants with respect to mechanisms and/or intermediate species
formation during aggregation (Flagmeier et al., 2016). Many ques-
tions regarding lipid–α-synuclein interactions remain, especially with
respect to modulation of amyloid formation pathways. Here, we used
biophysical methods and purified proteins to study the consequences
on protein aggregation upon interaction of WT and A53T α-
synuclein with small unilamellar lipid vesicles (SUVs) composed of
phosphatidylcholine, phosphatidylethanolamine (zwitterionic lipids),
phosphatidylserine (negatively charged lipid) and cholesterol to




sn-glycero-3-phosphoethanolamine (DOPE) and 1,2-dioleoyl-
sn-glycero-3-phospho-L-serine, sodium salt (DOPS) chloroform
solutions were purchased from Avanti Polar Lipids. Cholesterol
(≥99%), sodium phosphate monobasic (NaH2PO4; ≥99%), sodium
phosphate dibasic (Na2HPO4; ≥99.0%), ethylenediaminetetraacetic
acid (EDTA) (≥99%), sodium azide (≥99.5%) and thioflavin T (ThT)
UltraPure Grade (≥95%) were purchased from Sigma-Aldrich.
Protein expression and purification
Human WT and A53T α-synuclein were expressed in Escherichia
coli. The proteins were prepared by transforming their constructs
into BL21 (DE3) (Novagen) cells. The bacteria were first grown to an
OD600 of 0.6 in Luria broth (LB) containing 100 μg/ml carbenicillin
at 37◦C and then induced with 1 mM IPTG (isopropyl β-d-1-
thiogalactopyranoside) followed by expression overnight at 25◦C.
The cells were harvested and then lysed by sonication on an ice
bath through a sonicator probe in pulse mode in 20 mM Tris-HCl
buffer pH 8.0 in the presence of protease inhibitor cocktail (Roche).
After the sonication, the lysate was treated with a universal nuclease
(Pierce) for 15 min at room temperature. The lysate was then heated
at 90◦C for 10 min and centrifuged for 30 min at 15 000g. The
supernatant was filtered through 0.2 μm filter, loaded on to a pre-
equilibrated 5 ml HiTrap Q FF anion exchange column (GE Health-
care) and eluted by linear gradient with 1 M NaCl in 20 mM Tris-HCl
buffer pH 8.0. Fractions containing WT or A53T α-synuclein were
combined and concentrated with Ultra-15 Ultracel 10K centrifugal
filter devices (Millipore). The concentrate was loaded on to Hiload
16/600 Superdex 75 pg column (GE Healthcare) and retrieved in
20 mM Tris-sulfate buffer pH 7.4. For all purified proteins, the
sample purity was confirmed by a single band on SDS-PAGE gel and
a single elution peak in size exclusion chromatography. Fractions
containing pure protein were pooled, frozen in liquid nitrogen and
stored at −80◦C. The concentration of WT and A53T α-synuclein
was determined using ε280 = 5960 M
−1 cm−1.
Seed fibril formation
Seed fibrils of WT and A53T α-synuclein were produced by incubat-
ing 500 μl of 200 μM of each protein in 20 mM Tris-sulfate buffer,
pH 7.4, for 48 h at 37◦C under agitation with three glass beads of
2 mm using an Eppendorf ThermoMixer
®
C (speed set to 800 rpm).
Fibrils were diluted with 20 mM phosphate buffer, pH 6.5, to a
monomer equivalent concentration of 50 μM and sonicated for 10 s
using a probe sonicator (stepped microtip and Ultrasonic Processor
Sonics Vibra-Cell) at an amplitude of 20% and alternating cycle of
5 s on and 5 s off.
Lipid vesicle preparation
DOPC:DOPS:DOPE:cholesterol vesicles with a molar ratio of
30:20:25:25 were prepared by the lipid film hydration method.
Appropriate volumes of chloroform solution of the lipids DOPC,
DOPS, DOPE and cholesterol were transferred to a round bottom
flask, and the organic solvent was removed by rotary evaporation.
The resultant film was further dried under vacuum for at least 3 h
and then hydrated with 20 mM phosphate buffer, pH 6.5, and with
1 mM EDTA. The size of the liposomes was reduced by sonication
on ice for 12 min (ultrasonic probe with an amplitude of 40%,
pulse on 10 s, off 50 s). The size of the liposomes was measured
by dynamic light scattering using a Zetasizer Nano ZS instrument
(Malvern Instruments Ltd, UK).
Circular dichroism spectroscopy
Far-UV circular dichroism (CD) spectra of WT and A53T α-synuclein
(5 μM) titrated with liposomes were recorded at 37◦C on a Jasco J-
810 spectropolarimeter. CD spectra between 260 and 190 nm were
obtained using a quartz cuvette with a path length of 1 mm, a
bandwidth of 1 nm, a step size of 1 nm and a scanning speed of
50 nm/min. Three individual spectra were acquired and averaged for
each condition. A mock titration of liposomes into buffer without
protein was used to obtain control curves, which were subtracted
from the CD signal of the protein samples. Corrections for dilution
during the titration were made, and the resulting intensities in millide-
grees were converted to mean residue molar ellipticity. CD titration
curves were fitted using a one-step binding model: F + LipidL B
(Lipid)L, where F and B are the fractions of α-synuclein (αS) protein
free in solution and bound to the vesicles, respectively, and L is the
number of lipid molecules per one molecule of protein (Galvagnion













[αS] = [F] + [B] (2)[
Lipid
] = L ([LipidL] + [B(Lipid)L
])
(3)
CD signals can be expressed as a sum of contributions from
α-synuclein (αS) protein bound to the vesicles, xB = [B]/[αS], and
free in solution, xF = [F]/[αS]:
xB + xF = 1 (4)
CD = xBCDB + xFCDF (5)
where CDB and CDF are the CD signals of the protein bound and
free, respectively.
From equations (4) and (5):
xB = CD − CDFCDB − CDF
(6)
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And from equations (1)–(4):
xB =
(








The CD titration curves were fitted using equations (6) and (7)
and Matlab software.
Linear dichroism spectroscopy
Linear dichroism (LD) spectra were recorded on a Chirascan CD
spectrometer between 200 and 350 nm in 1 nm increments at a
time per point of 0.7 s and a bandwidth of 1 nm. The alignment
of the liposomes was achieved by a custom-made outer-cylinder-
rotation Couette flow cell with a path length of 1 mm. The shear
rate was 3100 s−1. Baselines at zero shear gradients were collected
and subtracted from all spectra. The macroscopic orientation of the
membrane was probed using curcumin absorption band at 424 nm
(Rocha et al., 2016). Stock solutions of curcumin (Sigma-Aldrich)
were prepared with ethanol (99.7%), and a specific volume (less than
0.5% of the total sample volume) was added to the vesicles in order
to have a final concentration of about 2 μM. The measurements were
done in a high viscosity buffer (containing 50 wt% sucrose) to reduce
the light scattering of the liposomes by matching their refractive index
(Ardhammar et al., 2002; Rocha et al., 2016).
Measurement of aggregation kinetics
Each protein was loaded on a gel filtration column prior to setting
up the kinetic measurements and eluted with 20 mM phosphate
buffer, pH 6.5, and with 1 mM EDTA. Samples containing WT or
A53T variant (30 or 50 μM), 12 mM sodium azide, 20 μM ThT
and vesicles at lipid concentrations of 0.75, 1.25, 2 and 3 mM were
prepared. A volume of 50 μl/well of each sample was incubated in
non-binding polystyrene 96-well half-area plates with clear bottom
(Corning Life Sciences) at 37◦C in the presence of a glass bead under
agitation (5 min before each measurement). For the seeding exper-
iment, preformed fibrils were added to the samples and the plates
were incubated under quiescent conditions. The ThT fluorescence
signal was monitored every 20 min (excitation wavelength 440 nm,
emission wavelength 480 nm) using a microplate reader (FLUOstar
Optima, BMG Labtech).
Atomic force microscopy
For atomic force microscopy (AFM) imaging, samples were diluted
with Milli-Q water (10–20 times) and deposited on freshly cleaved
mica. After 15 min, the mica was rinsed with Milli-Q water and dried
under a gentle nitrogen stream. Images were recorded in intermittent
contact mode in air using an NTEGRA Prima setup (NT-MDT) and a
gold-coated single crystal silicon cantilever (NT-MDT, NSG01, spring
constant of ∼5.1 N/m) and a resonance frequency of ∼180 kHz.
Images were analyzed using the Gwyddion software.
Results
Binding of WT and A53T α-synuclein to synaptic-like
vesicles
We measured the far-UV CD spectra of WT and A53T α-synuclein in
the presence of SUVs composed of DOPC:DOPS:DOPE:cholesterol
(at a molar ratio of 30:20:25:25), and we find the α-helix content of
the proteins to increase as a function of [lipid]:[protein] (L/P) ratios
(Fig. 1). As previously observed for other lipid vesicles, the CD signal
Fig. 1 Structural changes of WT and A53T α-synuclein at pH 6.5 in the presence
of DOPC:DOPS:DOPE:cholesterol SUVs at different L/P ratios. CD signal at
222 nm (left graph; the fit to a single-step binding model is represented by
the lines) and CD spectra of the proteins in the presence of vesicles at a L/P
ratio of 300 (on the right). The protein concentration was 5 μM.
at 222 nm of the proteins varies almost linearly with increasing SUV
concentration until saturation is attained. The data are well described
by a one-step binding model similar to previous studies (Galvagnion
et al., 2015; Kiskis et al., 2017). The number of lipid molecules
associated with each protein, L, and the lipid–protein dissociation
constants KD, obtained from the fits, are similar for WT (L = 143,
KD = 2.5 × 10−8 M) and A53T (L = 137, KD = 6.5 × 10−8 M).
Orientation of WT and A53T helices at synaptic-like
membrane
We probe the orientation of WT and A53T α-synuclein at the
membrane by flow LD, which is defined as the difference in the
absorption between parallel and perpendicularly polarized light and
reports on the orientation of the electronic transition moments. Thus,
the technique requires samples to have a net orientation, which here
is attained by subjecting the vesicles to shear flow in a Couette cell.
If protein molecules are randomly oriented, then LD = 0. However,
proteins bound to the vesicles are aligned relative to the flow and
expected to give an LD signal at their absorption bands (Caesar
et al., 2009). The geometry of the experiment is as follows: the flow
direction creates the long axis of the vesicle but the membrane normal
(which is perpendicular to the vesicle long axis) is the molecular
orientation direction (Nordén et al., 2010; Rocha et al., 2016). The
alignment of the DOPC:DOPS:DOPE:cholesterol SUV vesicles was
confirmed by adding the probe curcumin, which binds to the mem-
brane surface (Fig. S1) (Rocha et al., 2016). The LD spectrum of
WT and A53T proteins bound to vesicles at a L/P ratio of 28 is
dominated by a negative LD band at around 225 nm and a strong
positive maximum at ∼208 nm (Fig. 2). Typical absorption spectra of
α-helices in the region 180–240 nm region show features of the n–π∗
amide transition at ∼220 nm, which is perpendicularly polarized to
the helix axis, and the exciton coupling of the π–π∗ transition that
is split into two orthogonally polarized bands at 195 and 208 nm,
polarized perpendicular and along the helix axis, respectively. Thus,
LD experiments indicate that WT and A53T α-helices are oriented
with their long axis perpendicular to the membrane normal. Though,
the conformation of the membrane-bound helical segment of each
variant is slightly different as the ratio between the 208 and 225 nm
bands is not the same and the bands of WT are marginally shifted
to higher wavelengths, which could be an indication of a more
hydrophobic environment for the A53T helix. The absolute value of
the LD signal at 208 and 225 nm decreases over time, suggesting
a rearrangement of the orientation of the helices at the membrane
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Fig. 2 Orientation of WT and A53T α-synuclein at the vesicle surface monitored by LD in high viscosity buffer (20 mM phosphate buffer, 1 mM EDTA and 50% wt
% sucrose). The spectra were measured over 10 min (arrows indicate time in increasing order). The protein concentration was 30 μM and the L/P ratio was 28.
Inset shows the signal at 225 (circles) and 208 nm (triangles) as a function of time.
(Fig. 2). The weak band at around 280 nm in the LD spectrum of WT
is attributed to the Lb π–π
∗ transition of the aromatic residue tyro-
sine present in the N-terminal. There are four tyrosine residues in WT
and A53T variants, one in the N-terminal and three in the C-terminal.
The UV transition polarization at 280 nm arises probably from the
tyrosine present in the N-terminal (at position 39) since α-synuclein
binds to the membranes through the residues 1–100. The transition
moment of the UV absorption Lb (centered at 280 nm) of the benzene
ring of tyrosine is perpendicular to the symmetry axis (C1–C4) and
to the transition moment of the UV absorption La (around 230 nm),
polarized parallel with the symmetry axis (Fornander et al., 2014).
The La band is obscured due to overlapping absorption of the protein
backbone, whereas the negative LD in the Lb band region 250–
290 nm reveals that the Lb transition moment is oriented parallel
to the membrane normal. This band is barely visible in the A53T
LD spectra, supporting the hypothesis that the membrane-bound
structures of the two variants are somewhat different.
Aggregation of α-synuclein variants in the presence of
synaptic-like vesicles
We monitored, using the ThT fluorescence assay, the kinetics of
aggregation of WT and A53T α-synuclein in the presence of SUVs
at 37◦C under agitation with a borosilicate glass bead of 2 mm.
The presence of only protein monomers at the starting point was
ensured by performing gel filtration chromatography of the samples
directly prior to each aggregation experiment. The concentration
of the proteins was 50 μM and the L/P ratios (M/M) were 15
(0.75 mM total lipids), 25 (1.25 mM lipids), 40 (2 mM lipids) and
60 (3 mM lipids). Agitation in combination with a glass bead is used
to increase the reproducibility of fibrillation onset and the dominant
nucleation mechanism is thought to be fragmentation of the initially
formed fibrils (Giehm et al., 2011). We first confirmed that the
integrity of the liposomes is not affected by the presence of a glass
bead (Fig. S2).
The ThT fluorescence results of the proteins incubated with
a glass bead in the absence of SUVs show sigmoidal aggregation
profiles with a lag phase of around 23 h for WT and 7 h for the
A53T mutant, a growth phase until about 40 h for WT and 14 h for
Fig. 3 Protein aggregation under agitation in the presence of a glass bead
of 2 mm at pH 6.5 and 37◦C. ThT fluorescence when WT and A53T were
incubated in the absence and presence of SUVs at L/P ratios of 15, 25, 40
and 60. The protein concentration was 50 μM. The averages of four replicate
traces are shown in bold with individual traces dotted.
A53T followed by a plateau (Fig. S3). Under shaking and glass bead
conditions, we observed that the WT aggregation rates are affected
by SUVs at a L/P ratio of 25 or higher. For A53T, the aggregation
rate in the presence of SUVs remains fast and comparable to that
of the protein alone with higher final ThT fluorescence intensity
(Fig. 3). The normalized profiles show a small increase in the lag
phase from 7 to 11 h at the L/P ratio of 60 (lipid concentration of
3 mM) for A53T (Fig. 4). Maintaining the lipid concentrations (0.75,
1.25, 2, 3 mM) but decreasing the protein concentration from 50
to 30 μM, we observed that the α-synuclein aggregation rates slowed
down markedly in the presence of SUVs in a concentration-dependent
manner even for A53T (L/P ratios were 25, 42, 67, 100) (Fig. 4 and
Fig. S4). We note that in the absence of shaking and glass beads, and
regardless of the presence or absence of vesicles, the variants did not
show any change in the ThT fluorescence within the time frame that
our studies were conducted (75 h).
AFM analysis was performed for the end point samples contain-
ing 50 μM protein. Imaging of the two protein variants aggregated
under agitation with beads in the absence of vesicles shows fibrils
with heights of 5–7 nm. For L/P ratios of 60 for WT protein, condition
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Fig. 4 Normalized ThT fluorescence (top) and boxplot of half times (bottom)
of A53T incubated at 30 and 50 μM in the absence and presence of SUVs at
different L/P ratios.
in which the ThT plateau phase was not yet reached, spheroid
structures are also present (Fig. 5). In these cases, fibrils appear to
be attached to some of the spheroids, which are attributed to SUVs
as they appear similar to AFM analysis of vesicles alone (Fig. S2). It is
not possible to assess whether the fibrils are formed first in solution
and then bind to the vesicles or are formed at the membrane surface.
No vesicles/spheroids were detected by AFM in A53T samples of any
L/P ratio.
Effect of synaptic-like vesicles on the fibril elongation
of α-synuclein variants
We studied the influence of SUVs on fibril elongation by measuring
the aggregation kinetics of monomeric WT and A53T α-synuclein
(50 μM) in the presence of preformed seed fibrils at a concentration
of 5 μM (monomer equivalent) under quiescent conditions at pH 6.5
and 37◦C (Fig. 6). At high seed concentration (≥5% of the concentra-
tion of monomeric protein), the kinetics of the amyloid formation by
α-synuclein are dominated by elongation of the seed fibrils, and thus,
the aggregation profile is expected to be a single exponential function
as observed for WT and A53T variants at 50 μM incubated with 10%
of seed fibrils (Buell et al., 2014; Flagmeier et al., 2016). Though
there is a decrease in the final ThT intensity over seeded samples
in the presence of SUVs for both variants (Fig. S5), the elongation
rate seems to increase for WT, whereas it decreases for A53T with
increasing concentrations of vesicles (Fig. 6).
We then decreased the concentration of seed fibrils to 0.5 μM,
reducing therefore the rate of consumption of monomer by fibril
elongation. At this lower seed concentration, the time-resolved ThT
profiles of the proteins in the absence of SUVs become steeper with
time, indicating a growing (with time) contribution of secondary
processes (Buell et al., 2014). The presence of SUVs decreases the
overall intensity of the ThT fluorescence for aggregation of WT in
the presence of 1% seeds, but most notably, it changes the shape of
the kinetic trace from convex to concave, in particular, at L/P ratios
of 60 (Fig. 6). In contrast, the kinetic profiles of A53T aggregation
in the presence of 1% seed fibrils simply shift to the right with the
presence of SUVs (i.e. similar to at 10% seed fibrils), indicating an
overall delay in aggregation (Fig. 6).
Discussion
The first 25 residues of α-synuclein sequence are described to be
crucial for the membrane binding and for the initiation of the folding
of the protein (Bartels et al., 2010; Fusco et al., 2014). The removal
of only the two first residues is sufficient to change the protein
interaction with vesicles of a mixed lipid composition, decreasing
significantly both the affinity and the α-helix content when com-
pared to the full-length protein. Therefore, initial binding has been
attributed to the first 25 residues of the protein (Bartels et al., 2010).
Subsequently to the binding of the first 25 residues, the proposed
two-step interaction model states that residues 26–100 will next
cooperatively bind and fold (Bartels et al., 2010). Adopting this
model, it is not surprising that A53T mutant binds to vesicles and
forms α-helix structure much like as the WT protein and with similar
affinity. The number of lipid molecules interacting with the proteins
in the case of DOPC:DOPS:DOPE:cholesterol SUVs was found to be
higher than the numbers obtained previously for purely negatively
charged vesicles (Kiskis et al., 2017). The number of DOPS lipid
molecules per WT protein was 83, compared to 143 obtained here
for DOPC:DOPS:DOPE:cholesterol SUVs, which could be attributed
to reduction of the charge density of the membrane in the latter.
The electrostatic nature of the interaction between the α-synuclein
variants and SUVs is supported by the fact that, in the presence
of 150 mM NaCl, the α-helix content of the proteins induced
by the vesicles is considerably lower than that in the absence of
salt (Fig. S6).
The amphipathic helices of vesicle-bound WT and A53T variants
are oriented parallel to the membrane surface similar to what has
been described in the literature for WT α-synuclein (Ulmer et al.,
2005; Jao et al., 2008; Bodner et al., 2009; Lokappa and Ulmer,
2011; Robotta et al., 2011). However, the LD measurements showed
that the orientation and/or conformation of the membrane-bound
WT and A53T at L/P ratios of 28 is not the same as the ratio of the
208 and 225 nm bands differs between the proteins. The LD signal
from the polypeptide backbone of the membrane-bound variants
decreases in magnitude over time, which is an indication of protein
orientation changes and/or membrane changes. Membrane disrup-
tion would result in a poor vesicle alignment and consequently in the
drop of the protein LD signal. The LD changes could also be due to
insertion of parts of the helix in the membrane. It is interesting to note
that the Lb transition moment of tyrosine (280 nm band) observed for
the WT, though weak, does not change over time, strongly suggesting
that the changes observed in the α-helix absorption bands are not due
to membrane disruption. The variations in the LD spectra are likely a
result of overall alterations in the orientation and/or conformation of
the proteins combined with local lipid ordering changes triggered by
the variants since α-synuclein is known to induce lateral expansion of
lipids, thinning of the bilayer and positive mean curvature as well as
local negative Gaussian curvature in membranes (Braun et al., 2012;
Ouberai et al., 2013).
A quantitative understanding of the aggregation of WT and
A53T α-synuclein is difficult to attain due to the complexity and
heterogeneity of the process. In this study, similarly to other works,
we observed that the overall rate of α-synuclein aggregation increases
in the case of the A53T mutation. However, how this single-point
mutation changes the kinetics of the amyloid fibril formation is not
completely understood (Conway et al., 2000; Lemkau et al., 2012;
Flagmeier et al., 2016). Here, the aggregation of WT and A53T α-
synuclein occurred in the presence of a glass bead under shaking
conditions, which induce bubble formation leading to an increase of
the area of the air–water interface, which in turn enhances nucleation
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Fig. 5 AFM images of WT and A53T fibrils obtained after incubation of 50 μM of protein monomers at pH 6.5 and 37◦C for 75 h in the absence and presence of
SUVs at L/P ratios of 25 and 60. Spheroid structures bound to fibrils (white arrows) at L/P ratios of 60 for WT protein are attributed to vesicles.
Fig. 6 Seeded aggregation kinetics of 50 μM WT and A53T α-synuclein
monomers at pH 6.5 and 37◦C in the presence of SUVs at L/P ratios of 15,
25, 40 and 60. The seed fibril concentrations are 10 and 1% of the monomer
concentration at time 0. The kinetic curves for L/P ratios of 15 and 25 for the
WT protein with 5 μM seeds overlap. The data are presented as normalized
ThT fluorescence intensity versus time, with four replicates shown as dotted
traces and their averages represented by a continuous line. These data are
shown non-normalized in Fig. S7.
(Giehm et al., 2011; Campioni et al., 2014). In addition, under
agitation, the fragmentation is favored as it is a more effective source
of additional fibrils than primary nucleation. Therefore, the lag time
and maximal growth rate will depend primarily on amyloid fibril
breakage rates (Knowles et al., 2009). Initially, in the absence of fib-
rils, oligomers are formed by primary nucleation, but once a critical
concentration of amyloid fibrils is exceeded, the secondary process
will dominate (Knowles et al., 2009). The critical concentration of
monomers at equilibrium with fibrils for A53T was found to be
similar to that for WT, and thus, the faster aggregation of A53T
was attributed to different nucleation rates rather than a decrease of
monomer solubility or increase of fibril stability (Wood et al., 1999).
The mutation of alanine at position 53 to threonine seems to increase
the β-sheet structure formation and reduce the intramolecular long-
range interactions in the N-terminal region in comparison to the WT
protein, which could explain the higher propensity of A53T to aggre-
gate (Bussell and Eliezer, 2001; Bertoncini et al., 2005; Camilloni and
Vendruscolo, 2013; Coskuner and Wise-Scira, 2013).
Interestingly, under shaking conditions (i.e. secondary processes
dominate), we observe that synaptic vesicle mimics significantly
reduce the aggregation rate of WT already at 50 μM at the L/P ratios
of 40 and 60, but not that of A53T α-synuclein. However, the overall
aggregation rate of A53T was decreased by vesicles when the protein
concentration was reduced to 30 μM. Assuming that the fraction of
protein bound is about 40% at L/P ratios of 60 (determined from the
CD data), the amount of free monomers in samples containing 50 μM
A53T variant would be ∼30 μM. We observe that the aggregation
rates of samples with 50 μM protein and SUVs at L/P ratios of 60
are not comparable to those obtained at a monomer concentration
of 30 μM (Fig. S7). Thus, these results cannot be explained simple
by depletion of monomers from the solution due to the interaction
with SUVs, as previously suggested (Galvagnion et al., 2015). Instead,
our findings indicate that protein assemblies such as oligomers or
fibrils might interact with the vesicles, in addition to monomers.
Previous studies demonstrated that dimers of WT and A53T variants
bind to lipid vesicles with higher affinity than monomers (Giannakis
et al., 2008). Moreover, there are structural variations in oligomeric
species between WT and A53T variants, and conversion between
different types of oligomers is much faster for A53T mutant than
for WT (Tosatto et al., 2015). Thus, variations in oligomer structures
and interconversion rates between A53T and WT may explain the
observed data in the presence of SUVs.
Aggregation experiments performed in the presence of 10% seed
fibrils (i.e. condition where elongation dominates) under quiescent
conditions demonstrated that the vesicles slow down elongation
of A53T but accelerate that of WT. At conditions where the rate
of consumption of monomer by fibril elongation is reduced (1%
seed fibrils), the decrease of overall aggregation by SUVs remains
for A53T, whereas the aggregation mechanism of WT appears to
change. The aggregation of WT at 1% seed fibrils is still accelerated
by SUVs, but the shape of the curves is distinctly altered when
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SUVs are added. We previously described a hidden amyloid for-
mation pathway involving oligomeric WT α-synuclein species that,
when bound to membranes, acted as templates for linear growth of
thin fibrils and inhibit the typical cooperative aggregation seen for
monomers (Kiskis et al., 2017). Something similar may take place
in the current experiments: in fact, the shapes of the ThT curves
for WT with 1% seed fibrils in the presence of SUVs are similar
to the curves found for 10% seed fibrils. This implies that, in the
presence of SUV, elongation becomes highly favored despite a low
seed level.
Taken together, our study shows that the overall aggregation
rate of the two α-synuclein variants WT and A53T decreases in the
presence of vesicles, but the microscopic steps in the aggregation
mechanisms are clearly affected differently. We speculate that if
monomers and early-formed oligomers are depleted above a critical
concentration (by vesicle binding) then the protein aggregation is
delayed. In contrast, if the conversion to oligomers occurs fast enough
and they reach a critical concentration in solution, fibrils will be
formed rapidly independently of the presence of vesicles, which will
be most likely disrupted by the aggregates. The presence of seeds
eliminates the need for primary nucleation, and in this case, SUVs are
able to prevent the growth of A53T fibrils, whereas the elongation
mechanism is altered for the WT variant. AFM imaging showed that
amyloid fibrils can also bind to the vesicles, and this might depend
on their morphology and could affect their breakage properties.
Accordingly, α-synuclein mutants are known to form amyloids that
are morphologically distinct from WT amyloids (Heise et al., 2008;
Lemkau et al., 2013; Nielsen et al., 2013; Tosatto et al., 2015).
The A53T mutation was found to result in significant structural
rearrangements near the mutation site in the amyloid fibrils (Nielsen
et al., 2013). As a result A53T oligomers and amyloid fibers may
interact differently with vesicles as compared to WT α-synuclein.
To conclude, the present work shows that vesicles with synaptic-
like lipid membrane composition delay amyloid formation of WT
and A53T α-synuclein when the process is dominated by fibril frag-
mentation, but the impact of the vesicles on aggregation mechanisms
differs between the variants. On the one hand, the aggregation
rate of A53T is less reduced by vesicles than that of WT when
incubated under shaking conditions. On the other hand, vesicles
decrease the elongation rate of A53T but increase this rate for WT.
The observed differences are not due to differences in protein–vesicle
binding affinity; instead, they appear related to different rates of
interconversion and structural variations of intermediate, partially
assembled species of WT versus A53T. The results call for further
time-resolved studies focusing on the early steps of aggregation of
WT and A53T. Differences in aggregation mechanism, and thereby
different effects on cellular membranes, may be related to early onset
of PD in the case of A53T. From a technical point of view, we want
to highlight the use of LD as a complementary method to analyze
protein orientation on membranes.
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